02/14/2019 /
Low interictal HCVR may increase the risk of severe respiratory depression and SUDEP after GCS and warrants further study.
02/12/2019 /
These findings indicate that autoantibodies can induce seizures in anti-NMDAR encephalitis and offer a model for testing novel therapies for refractory autoimmune seizures.
02/12/2019 /
In this study, long-term add-on cannabidiol treatment had an acceptable safety profile in patients with Lennox-Gastaut syndrome and led to sustained reductions in seizures.
02/11/2019 /
Subjects mostly favored “person-first” terminology (“person having epilepsy” and “person with epilepsy”), and 53.9% disapproved of the term “epileptic”.
02/11/2019 /
Zogenix, Inc. announced it has completed its rolling submission of a New Drug Application (NDA) to the FDA for FINTEPLA for the treatment of seizures associated with Dravet syndrome.
02/08/2019 /
Discover the latest about what’s happening at CURE and in our community in the February 2019 CURE Update from Chief Scientific Officer, Laura Lubbers!
02/08/2019 /
Lisuride, an anti-parkinson medicine with demonstrated anti-seizure effects, was able to stop epileptic activity in a model of convulsant Dravet syndrome zebrafish, researchers report.
02/08/2019 /
New research confirms that if spreading depolarization of neurons engages the brainstem, the result is fatal.
02/07/2019 /
This study presents the first evidence for the effectiveness of fenfluramine in reducing seizure incidence, severity, and seizure-induced respiratory arrest susceptibility in a mammalian SUDEP model.
